Log in to save to my catalogue

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for lo...

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for lo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2564701768

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

About this item

Full title

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

Publisher

Singapore: Springer Singapore

Journal title

International journal of clinical oncology, 2020-11, Vol.25 (11), p.1914-1920

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Background
Docetaxel, cisplatin, and 5-fluorouracil (TPF) induction chemotherapy (ICT) is a treatment option for locally advanced unresectable head and neck squamous cell carcinoma (LA-HNSCC). However, patients with advanced age, or renal, cardiac or neurogenic dysfunction are ineligible for ICT-TPF.
Methods
We retrospectively assessed 24...

Alternative Titles

Full title

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2564701768

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2564701768

Other Identifiers

ISSN

1341-9625

E-ISSN

1437-7772

DOI

10.1007/s10147-020-01742-6

How to access this item